Neogen (NASDAQ: NEOG) revenue
Neogen reported revenue of $870.4m for fiscal 2026, 2.7% less than in fiscal 2025 ($894.7m). Since fiscal 2017 its revenue has grown by 142.9%, an average growth of 10.4% a year.
Neogen's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −3.2%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $870.4m | −2.7% | −$21.6m | −2.5% |
| 2025 | $894.7m | −3.2% | −$1,061m | −118.6% |
| 2024 | $924.2m | +12.4% | $58.6m | 6.3% |
| 2023 | $822.4m | +56.0% | $37.5m | 4.6% |
| 2022 | $527.2m | +12.5% | $58.6m | 11.1% |
| 2021 | $468.5m | +12.0% | $74.2m | 15.8% |
| 2020 | $418.2m | +1.0% | $67.5m | 16.1% |
| 2019 | $414.2m | +4.1% | $68.1m | 16.4% |
| 2018 | $397.9m | +11.1% | $70.2m | 17.6% |
| 2017 | $358.3m | — | $64.9m | 18.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Neogen revenue compared with its sector
By revenue for its latest fiscal year, Neogen ranks 161st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Neogen, −2.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 159th | BioCryst Pharmaceuticals | $874.8m | 94.1% |
| 160th | Warby Parker | $871.9m | 13.0% |
| 161st | Neogen | $870.4m | −2.7% |
| 162nd | Harmony Biosciences | $868.5m | 21.5% |
| 163rd | Varex Imaging | $844.6m | 4.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Neogen
- How much revenue did Neogen make in fiscal 2026?
- Neogen reported revenue of $870.4m for fiscal 2026, compared with $894.7m in fiscal 2025.
- How much has the revenue of Neogen grown?
- Between fiscal 2017 and fiscal 2026 it went from $358.3m to $870.4m: 142.9% more, an average growth of 10.4% a year.
- What was the best year for revenue at Neogen?
- Of its last 10 fiscal years, fiscal 2024, with $924.2m.
- Where does Neogen rank in its sector by revenue?
- It ranks 161st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Neogen come from?
- From the annual report (Form 10-K) that Neogen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Neogen files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Neogen: the Neogen page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.